Allon Announces Presentation of Davunetide Data During 10th...

12th March 2011, Comments 0 comments

Allon Therapeutics Inc. announced today that clinical and research data on the impact of the Company"s lead drug candidate davunetide, on Parkinson"s disease and other neurodegenerative conditions, are being presented during two sessions of the 10th International Conference on Alzheimer"s and Parkinson"s Disease this week in Barcelona, Spain.

0 Comments To This Article